Lupin Debuts on TIME–Statista’s World’s Most Sustainable Companies 2026 List

manufacturing-news
Image Courtesy: LUPIN

Global pharmaceutical company Lupin Limited has been recognised among the TIME and Statista World’s Most Sustainable Companies 2026, marking its debut on the prestigious global ranking that honours organisations demonstrating excellence in environmental, social and governance (ESG) performance. The company secured the 318th position among 750 companies selected from a pool of more than 5,000 of the world’s largest and most influential businesses.

The recognition highlights Lupin’s continued commitment to embedding sustainability across its global operations while advancing responsible business practices, environmental stewardship, transparent governance and meaningful social impact. The annual ranking evaluates organisations on more than 20 sustainability indicators, including environmental performance, social responsibility, governance standards, sustainability commitments, reporting transparency and external sustainability ratings. Lupin is one of only 16 Indian companies featured in this year’s global list, underscoring its growing leadership in integrating ESG principles into business strategy and long-term value creation.

Commenting on the recognition, Ramesh Swaminathan, Executive Director, Global CFO, Head of IT and API Plus SBU, Lupin, said, “Being included in TIME and Statista’s World’s Most Sustainable Companies 2026 is a significant milestone for Lupin. Sustainability is an integral part of our growth strategy and guides the way we operate across our global business. We remain focused on accelerating our climate action initiatives, strengthening governance and transparency, expanding renewable energy adoption, and embedding ESG principles across the organisation as we continue creating sustainable value for all our stakeholders.”

The latest recognition builds on Lupin’s strong sustainability track record and reflects its ongoing efforts to reduce environmental impact while enhancing operational resilience and responsible corporate governance. The company has consistently invested in initiatives aimed at improving energy efficiency, conserving natural resources, promoting ethical business practices and creating positive outcomes for patients, employees, communities and investors.

Lupin’s ESG leadership has also been acknowledged through several globally recognised benchmarks. The company received the highest ‘A’ Leadership rating from CDP for both Climate Change and Water Security, demonstrating excellence in environmental disclosure and performance. It also achieved an impressive S&P Global Corporate Sustainability Assessment (CSA) score of 91 in 2025, reflecting strong performance across environmental, social and governance parameters.

As sustainability increasingly becomes a key consideration for global businesses, Lupin continues to integrate ESG priorities into every aspect of its operations, from research and manufacturing to supply chain management and community engagement. The company believes that responsible growth and innovation go hand in hand, enabling it to create lasting value while addressing evolving healthcare and environmental challenges.

Headquartered in Mumbai, Lupin is one of the world’s leading pharmaceutical companies with a presence in more than 100 markets. Its portfolio includes branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients. The company maintains a strong presence across key therapeutic areas including respiratory, cardiovascular, diabetes, anti-infective, gastrointestinal, central nervous system and women’s health.

Supported by 15 manufacturing facilities, seven research centres and a workforce of more than 24,000 professionals worldwide, Lupin continues to strengthen its position as a global healthcare leader while advancing its commitment to sustainable and responsible growth.